Minimally Invasive Specialist Karina Hoan joins WoHX

Boston, MA -- September 16 2026: Women's HealthX has officially confirmed the addition of Dr Karina Hoan, Medical Director of Surgical Specialties at The Portland Clinic, to the marquee Day 1 panel faculty at the Encore Boston Harbor.

Dr Hoan joins the high-stakes session: Menopause Isn't Ignored, it's Underserved: The Economic Cost of Inconsistent Tracking, Treatment, and Innovation.

The Operational Conflict: Standardising the Invisible

For regional health systems and multi-facility clinical networks, managing midlife health trajectories has historically been a fragmented, under-tracked operational blindspot.

When symptoms, care pathways, and clinical outcomes are not uniformly recorded within Electronic Health Records (EHR), the true economic and operational cost of care remains entirely invisible to hospital boardrooms

As Medical Director of Surgical Specialties at one of the Pacific Northwest's premier multi-specialty physician groups, Dr Hoan operates at the absolute frontline of clinical protocol execution and care-coordination strategy.

Her oversight is critical in bridging the gap between specialized surgical pathways and everyday primary care integration, providing a precise blueprint for how complex health systems can standardise midlife health data to make it visible, measurable, and fiscally actionable

The Plenary Stage Alignment

Sitting face-to-face on the Day 1 afternoon plenary stage, Dr Hoan will align her system-level provider insights directly alongside fellow anchor panelist Eren Watkins, Director and R&D Chief of Staff at global biopharma giant Organon.

Together, this cross-functional powerhouse will dissect the practical mechanics required to:

• Standardise Midlife Metrics: Build unified data capture guidelines across health networks to ensure clinical treatments are consistently captured in EHR workflows.
• Systematise Care Delivery: Smoothly integrate specialized midlife clinical care straight into routine, everyday patient pathways to optimize patient care and improve clinician confidence.
• De-Risk Sourcing Pipelines: Drive institutional investment toward evidence-based innovation, moving procurement committees past outdated therapies and inconsistent care standards.

Bypassing abstract clinical rhetoric, this track gives hospital COOs, health plan medical directors, and life sciences innovators the exact operational data needed to insulate their 2027 healthcare infrastructure from systemic care fragmentation.